China Nod At Regulatory Improvements Will Widen Doors For US Medtech
This article was originally published in Clinica
Chinese officials have agreed to address regulatory challenges to improve access for US firms to China's medical device market following talks with American counterparts and medical device industry representatives. The targeted reforms include lowering clinical trial barriers for some class II and class III devices.
Register for our free email digests: